Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
22343 | 328 | 25.0 | 50% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | INDAPAMIDE | Author keyword | 24 | 31% | 20% | 65 |
2 | CLIN NUTR METAB DIS | Address | 4 | 75% | 1% | 3 |
3 | PHARMACOL PHYSIOPATHOL CARDIOVASC | Address | 4 | 75% | 1% | 3 |
4 | METHYCLOTHIAZIDE | Author keyword | 2 | 67% | 1% | 2 |
5 | CAS 26807 65 8 | Author keyword | 1 | 100% | 1% | 2 |
6 | ISOLATED ADULT RAT CARDIOMYOCYTE | Author keyword | 1 | 100% | 1% | 2 |
7 | LAUROYL INDAPAMIDE | Author keyword | 1 | 100% | 1% | 2 |
8 | ANTIATHEROGENICITY | Author keyword | 1 | 50% | 0% | 1 |
9 | AORTIC STRUCTURE | Author keyword | 1 | 50% | 0% | 1 |
10 | AUSTRALIA CLIN EXCELLENCE THER EUT | Address | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INDAPAMIDE | 24 | 31% | 20% | 65 | Search INDAPAMIDE | Search INDAPAMIDE |
2 | METHYCLOTHIAZIDE | 2 | 67% | 1% | 2 | Search METHYCLOTHIAZIDE | Search METHYCLOTHIAZIDE |
3 | CAS 26807 65 8 | 1 | 100% | 1% | 2 | Search CAS+26807+65+8 | Search CAS+26807+65+8 |
4 | ISOLATED ADULT RAT CARDIOMYOCYTE | 1 | 100% | 1% | 2 | Search ISOLATED+ADULT+RAT+CARDIOMYOCYTE | Search ISOLATED+ADULT+RAT+CARDIOMYOCYTE |
5 | LAUROYL INDAPAMIDE | 1 | 100% | 1% | 2 | Search LAUROYL+INDAPAMIDE | Search LAUROYL+INDAPAMIDE |
6 | ANTIATHEROGENICITY | 1 | 50% | 0% | 1 | Search ANTIATHEROGENICITY | Search ANTIATHEROGENICITY |
7 | AORTIC STRUCTURE | 1 | 50% | 0% | 1 | Search AORTIC+STRUCTURE | Search AORTIC+STRUCTURE |
8 | COMBINATION PREPARATION | 1 | 50% | 0% | 1 | Search COMBINATION+PREPARATION | Search COMBINATION+PREPARATION |
9 | CONDUCTANCE VESSEL | 1 | 50% | 0% | 1 | Search CONDUCTANCE+VESSEL | Search CONDUCTANCE+VESSEL |
10 | ETOZOLIN | 1 | 50% | 0% | 1 | Search ETOZOLIN | Search ETOZOLIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INDAPAMIDE | 4 | 18% | 6% | 20 |
2 | DECREASES BONE RESORPTION | 1 | 100% | 1% | 2 |
3 | ETOZOLINE | 1 | 100% | 1% | 2 |
4 | PREVENTS STROKE | 1 | 30% | 1% | 3 |
5 | CHANNEL OPENING PROPERTIES | 1 | 50% | 0% | 1 |
6 | FLUNOXAPROFEN | 0 | 33% | 0% | 1 |
7 | PIG RESISTANCE ARTERIES | 0 | 33% | 0% | 1 |
8 | STABILITY INDICATING METHOD | 0 | 33% | 0% | 1 |
9 | TERM ACE INHIBITION | 0 | 33% | 0% | 1 |
10 | DELAPRIL | 0 | 25% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
INDAPAMIDE - A REVIEW OF ITS PHARMACODYNAMIC PROPERTIES AND THERAPEUTIC EFFICACY IN HYPERTENSION | 1984 | 74 | 80 | 73% |
Pharmacological properties of indapamide - Rationale for use in hypertension | 1999 | 11 | 23 | 57% |
Delapril plus indapamide - A review of the combination in the treatment of hypertension | 2007 | 1 | 44 | 36% |
Cardiovascular effects of diuretics. | 1996 | 0 | 18 | 28% |
INDAPAMIDE - A REVIEW | 1983 | 0 | 41 | 32% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CLIN NUTR METAB DIS | 4 | 75% | 0.9% | 3 |
2 | PHARMACOL PHYSIOPATHOL CARDIOVASC | 4 | 75% | 0.9% | 3 |
3 | AUSTRALIA CLIN EXCELLENCE THER EUT | 1 | 50% | 0.3% | 1 |
4 | DIPARTIMENTO CARDIOTHORAC | 1 | 50% | 0.3% | 1 |
5 | INSERME9920 | 1 | 50% | 0.3% | 1 |
6 | RECH CORDELIERSEQUIPE 3 | 1 | 50% | 0.3% | 1 |
7 | RENAL GENOM PHYSIOL PATHOPHYSIOL | 1 | 50% | 0.3% | 1 |
8 | UMRS 872TEAM 3 | 1 | 50% | 0.3% | 1 |
9 | SUPERACID GRP | 0 | 33% | 0.3% | 1 |
10 | U644IFRMP 23 | 0 | 33% | 0.3% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000172301 | CICLETANINE//CA 2 ACTIVATED POTASSIUM CHANNEL//ELECTROTONIC PROPAGATION |
2 | 0.0000126852 | ICI 206 970//POTASSIUM BLOOD//EUKALEMIC |
3 | 0.0000124863 | TORASEMIDE//TORSEMIDE//FUROSEMIDE |
4 | 0.0000120588 | AMILORIDE DETERMINATION//FUROSEMIDE DETERMINATION//CHERRY SYRUP |
5 | 0.0000117185 | DOXAZOSIN//AJ 2615//MONATEPIL MALEATE |
6 | 0.0000106458 | UNITE PHARMACOEPIDEMIOL EA 3696//BLOOD POTASSIUM//HYPERGLUCAGONAEMIA |
7 | 0.0000088174 | AMLODIPINE//BLOOD PRESSURE CONTROL//ANTIHYPERTENSIVE THERAPY |
8 | 0.0000077646 | QUEER FICTION//ISOINDOLINES//ANTIINFLAMATORY |
9 | 0.0000066490 | INHALED FUROSEMIDE//ULTRASONICALLY NEBULIZED DISTILLED WATER INHALATION CHALLENGE//FRUSEMIDE |
10 | 0.0000063293 | MYOCARDIAL COLLAGEN CONCENTRATION//HYPERTROPHY REVERSAL//REGIONAL SYMPATHETIC ACTIVITY |